Suchergebnisse - "Barrera-Chimal, Jonatan"

PubPharm (79)

1

Tungsten toxicity on kidney tubular epithelial cells induces renal inflammation and M1-macrophage polarization

enthalten in: Cell biology and toxicology | 2023

von Barrera-Chimal, J. | Henley, N. | Grant, M. | +4

2

Kinin B1 Receptor Antagonism Prevents Acute Kidney Injury to Chronic Kidney Disease Transition in Renal Ischemia-Reperfusion by Increasing the M2 Macrophages Population in C57BL6J Mice

enthalten in: Biomedicines | 2023

von Estrela, G. | Santos, R. | Budu, A. | +3

3

FLT4 activation promotes chemoresistance in pediatric leukemia through stabilization of MDM2/MDMX and inactivation of p53

enthalten in: ResearchSquare.com | 2023

von Dubuissez, M. | Haferssas, D. | Barrera-Chimal, J. | +5

4

Mineralocorticoid receptor antagonists : A new therapeutic option for diabetic kidney disease

enthalten in: Medecine sciences : M/S | 2023

von Girerd, S. | Soulie, M. | Barrera-Chimal, J. | +1

5

The mineralocorticoid receptor in chronic kidney disease

enthalten in: British journal of pharmacology | 2022

von Barrera-Chimal, J. | Jaisser, F. | Anders, H.

6

The non-steroidal mineralocorticoid receptor antagonist finerenone is a novel therapeutic option for patients with Type 2 diabetes and chronic kidney disease

enthalten in: Clinical science (London, England : 1979) | 2022

von Barrera-Chimal, J. | Gerarduzzi, C. | Rossignol, P. | +1

7

Hepatocyte growth factor reverses cholemic nephropathy associated with α-naphthylisothiocyanate-induced cholestasis in mice

enthalten in: Life sciences | 2022

von Salas-Silva, S. | López-Ramirez, J. | Barrera-Chimal, J. | +9

8

Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease

enthalten in: Kidney international supplements | 2022

von Nakamura, T. | Girerd, S. | Jaisser, F. | +1

9

Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases

enthalten in: Annual review of physiology | 2022

von Barrera-Chimal, J. | Bonnard, B. | Jaisser, F.

10

Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects

enthalten in: Nature reviews. Nephrology | 2022

von Barrera-Chimal, J. | Lima-Posada, I. | Bakris, G. | +1

1
2
3
4
5
6
7
8
Nächster »
[8]